Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Clinical features and therapeutic outcomes of acromegaly during the recent 5 years: single centre experience

ea0035p839 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Clinical evaluation of follow-up of 62 patients: do treatment methods in acromegaly affect the rates of cure and hypophyseal insufficiency?

ea0035p843 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Improvement of quality of life in acromegalic patients evaluated by AcroQoL in Korea

ea0035p844 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Enormous, LH secreting gonadotroph adenoma in a male patient

ea0035p845 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

NFPA and hypopituitarism: a retrospective analysis of 260 patients and focus on the prevalence of isolated hypoadrenalism

ea0035p846 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Resolution of severely impaired cognitive function following medical treatment of cystic invasive giant prolactinoma

ea0035p847 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

TSH-secreting pituitary adenoma treated conservatively with cabergoline for more than 10 years

ea0035p848 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

An audit of hyponatraemia in a large UK university teaching hospital

ea0035p849 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

A statistical model of patient satisfaction after surgery for non-functioning macroadenomas of the pituitary gland

ea0035p850 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Endocrine abnormalities in primary empty sella

ea0035p851 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

What is in the sella while spying on cancer? The role of FDG–PET/CT in differential diagnosis of sellar mass during staging for malignant disease

ea0035p852 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Lymphocytic hypophysitis: natural history and management in the 21st century

ea0035p853 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Assessment of the hypothalamus–pituitary–adrenal axis with different corticotropin tests in adult patients with Prader–Willi syndrome

ea0035p854 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Mean platelet volume in male hypogonadotropic hypogonadysm: the relationships among with MPv, low testosterone levels, metabolic syndrome, impaired fasting glucose and cardiovascular risk

ea0035p855 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

The effects of octreotide acetate long-acting repeatable on mean platelet volume in acromegaly: octreotidelar may have a detrimental effect on MPV, a new indicator of atherosclerosis

ea0035p856 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

GH replacement therapy during pregnancy in a patient with Sheehan's syndrome

ea0035p857 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Constipation in elderly men, the initial manifestation of empty sella

ea0035p858 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

A case of IgG4-related xanthomatous hypophysitis

ea0035p859 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Pituitary abnormalities in short adolescents and young adults with sickle-cell disease and recurrent vaso-occlusive crisis

ea0035p860 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Evolution of glucose tolerance status after treatment of acromegaly: a prospective study in 57 patients

ea0035p861 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Serum prolactin in advanced chronic liver disease

ea0035p862 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Assessment the relationship between TSH and selected anthropometric parameters: preliminary report

ea0035p863 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Is pregnancy possible with acromegaly?

ea0035p864 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

A case of lymphocytic hypophysitis presented as hemorrhagic pituitary macroadenoma

ea0035p865 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Effect of chronic treatment with cabergoline and testosterone replacement on metabolic parameters in male patients with prolactinomas and hypogonadism

ea0035p866 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

A middle aged woman with isolated ACTH deficiency associated with transient GH deficiency

ea0035p867 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Sterile pituitary abscess associated with hypophysitis and panhypopituitarism: case report

ea0035p868 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Pathological findings in kidneys of acromegalic patients

ea0035p869 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

A case with acromegaloidism

ea0035p870 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Colon cancer metastatic to the pituitary gland: a case report

ea0035p871 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Acut monocytic leukemia with pituitary involvement; a case report

ea0035p872 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Late onset postpartum diabetes insipidus: a case report

ea0035p873 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Abnormalities of midline and GH deficiency: about 160 cases

ea0035p874 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Acromegaly and schizophrenia: an incidental association?

ea0035p875 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Pre-surgical medical treatment, a major prognostic factor of remission in acromegaly

ea0035p876 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Preoperative octreotide treatment of acromegaly: long-term results of a randomized, controlled study

ea0035p878 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

A case with macroprolactinemia and gigantomastia responding to cabergoline treatment

ea0035p879 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Comprehensive geriatric assessment of elderly cases with acromegaly

ea0035p880 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Somatostatin analogue treatment of a TSH secreting adenoma presenting with accelerated bone metabolism and a pericardial effusion

ea0035p881 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Normal health-related quality of life can be achieved in patients with functional pituitary adenomas having surgery as primary treatment

ea0035p882 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Comparison of the effectiveness of bromocriptine and cabergoline treatment of microprolactinomas in women based on results of dynamic pituitary gland MRI

ea0035p883 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

A case of become pregnant woman with active acromegaly during Octreatide LAR treatment

ea0035p884 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Register of sellar tumors: RESET: diagnostics and therapy of acromegaly in Czech and Slovak Republics

ea0035p885 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Study Design of a Phase II trial of pasireotide s.c. alone or in combination with cabergoline in patients with Cushing's disease

ea0035p886 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

An acromegalic patient with history of renal transplantation

ea0035p887 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Anterior and posterior pituitary functions in male prolactinomas

ea0035p888 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Hyperprolactinemia and chiasmic syndrome in patients with non functioning pituitary tumors

ea0035p889 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Acromegalic arthropathy: clinical presentation, treatment and quality of life

ea0035p890 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Analysis of metabolic alterations within the normal appearing brain in children with GH deficiency: MR spectroscopy and hormonal correlation

ea0035p891 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Pituitary non-secreting micro-incidentalomas and endocrine dysfunctions: a retrospective analysis in 236 Romanian patients

ea0035p892 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Pituitary incidentaloma: an age-related study in 266 Romanian patients

ea0035p893 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Post-partum pituitary insufficiency: diagnostic challenge

ea0035p894 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

‘High dose hook effect' in a patient with invasive giant prolactinoma

ea0035p895 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Six cases of FSH/LH positive pituitary adenomas

ea0035p896 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Long-term efficacy and withdrawal of octreotide LAR in acromegaly patients, a prospective single centre study with 4 years follow-up

ea0035p897 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

A case of an isolated ACTH deficiency who had a prolonged QT interval

ea0035p898 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Recurrence of hyperprolactinemia after withdrawal of cabergoline in prolactinomas

ea0035p899 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Langerhans cell histiocytosis: a case report

ea0035p900 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Diabetes insipidus secondary to hypothalamus and pituitary metastasis

ea0035p901 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

How to get surgical remission rates in ACTH-microadenomas close to 100% using minimally invasive approaches for diagnosis and surgery

ea0035p902 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Prolactin hyperproduction does not predict the risk of glucose metabolic disturbances in patients with acromegaly

ea0035p903 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Cushing's disease: the dynamics of serum cortisol concentrations after successful transsphenoidal surgery and the restoration of the adrenal cortex function

ea0035p904 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Alternative method of macroprolactin evaluation as a cause of hyperprolactinaemia

ea0035p905 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Effect of pasireotide on GH, IGF1, IGFBP2, IGFBP3, HbA1C and glucose in patients with inadequately controlled acromegaly: exploratory results from a multicentre, randomized, 24-week study (PAOLA)

ea0035p906 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Somatostatin analogues treatment did not modify glucose control in acromegalic, diabetic subjects

ea0035p907 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Pasireotide LAR demonstrates superior efficacy versus octreotide LAR and lanreotide ATG in patients with inadequately controlled acromegaly: results from a phase III, multicentre, randomized study (PAOLA)

ea0035p908 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

High prevalence of autoimmune thyroid diseases in females with prolactinomas: results from a cross-sectional case–control prospective study in a single tertiary referral centre

ea0035p909 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Hormonal deficiency in patients with craniopharyngioma

ea0035p910 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Relationship between early and longer-term tumour volume reduction (TVR) with primary lanreotide Autogel (LAN-ATG) therapy in treatment-naive acromegalic patients: post hoc analyses of the PRIMARYS study

ea0035p911 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Tumour and hormonal response with lanreotide Autogel 120 mg in treatment-naive acromegalic patients: further post hoc data from the PRIMARYS study

ea0035p912 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Efficacy and safety of lanreotide autogel (LAN-ATG) 120 mg at extended dosing intervals (EDIs) in acromegalic patients biochemically controlled with octreotide LAR (OCT-LAR) 10 or 20 mg: The LEAD study

ea0035p913 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Cortisol metabolites response in hypothalamic–pituitary–adrenal axis tests

ea0035p914 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Octreotide fluid crystal provides sustained octreotide bioavailability and similar IGF1 suppression to that of octreotide LAR (Sandostatin LAR): randomized, open-label, Phase I, repeat-dose study in healthy volunteers

ea0035p915 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Clinical case: Silent corticotroph pituitary macroadenoma transforming into Cushing disease.

ea0035p916 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Lanreotide-induced bradycardia and supraventricular extrasystoles

ea0035p917 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Treating prolactinoma by endoscopic endonasal pituitary surgery: surgical experience of 151 cases

ea0035p918 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Pharmacokinetic (PK) and pharmacodynamic (PD) analyses of pasireotide LAR and octreotide LAR: Randomized, double-blind Phase III study in patients with medically naive acromegaly

ea0035p919 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Copeptin in basal conditions and during water deprivation test in patients with polydipsic–polyuric disorders

ea0035p920 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

A case or recurrent pituitary apoplexy

ea0035p921 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Increased prevalence of differentiated thyroid carcinoma in patients with acromegaly

ea0035p922 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Oral and dental pathologies in patients with acromegaly

ea0035p923 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Relationship between growth hormone deficiency and oxidative stress in patients with heart failure: Preliminary data.

ea0035p924 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

GH Deficiency in HIV-infected patients compared to hypopituitary patients

ea0035p925 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Conservative management of pituitary apoplexy – own experience

ea0035p926 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Pituitary apoplexy: surgical or conservative management

ea0035p927 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Histiocytosis of pituitary gland: a case report

ea0035p928 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Diabetes inspidus post traumatic head injury

ea0035p929 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Malignancies in patients with pituitary adenomas

ea0035p930 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Psychosocial changes in patients with acromegaly: the preliminary results

ea0035p931 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Population-based cohort study: PROP1 gene mutations are the most prevalent cause of congenital multiple pituitary hormone deficiency in Lithuania

ea0035p932 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Cabergoline-induced pneumocephalus: an unusual complication of macroprolactinoma treatment

ea0035p933 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

An unusual cause of hypopituitarism

ea0035p934 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Russian registry of patients with tumors of the hypothalamic-pituitary region (OGGO): October 2013 update for acromegaly

ea0035p935 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Prevalence of thyroid dysfunction in naive acromegalic patients

ea0035p936 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Dilated cardiomiopathy and acromegaly

ea0035p937 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

IGF1 response to rhGH in adult GHD: role of GH receptor (GHR) isoforms

ea0035p938 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Markers of proliferation and invasion in somatotropinomas

ea0035p939 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Individual risk factors of metabolic syndrome in adult patients with GH deficiency: a cross-sectional case-control study

ea0035p940 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Assessment of glucose homeostasis alterations, inflammatory markers, and coagulation parameters following a successful transsphenoidal surgery for Cushing's disease: preliminary report.

ea0035p941 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Determinants of survival in treated patients with acromegaly

ea0035p942 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Surgical treatment of ACTH-secreting pituitary adenomas in nelson syndrome

ea0035p943 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

The impact of the Cushing's Disease remission in associated comorbidities

ea0035p944 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

Weight and metabolic profile evolution in patients with treated prolatinomas

ea0035p945 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>)

16th European Congress of Endocrinology

BiosciAbstracts